From: Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules
Pre-Test Risk
Post-Test Risk
Low Malignant Blood
High Malignant Blood
Low
Very Low
< 28%
< 25%
> 28%
> 25%
Intermediate
< 20%
< 11%
> 20%
11–97%
High
No call change
> 97%
Very High